Retina Summit
Karlsruhe 2009 - Final Program
Add to my FavoritesTell a Friend Tell a FriendAdd to my Favorites

Scientific program

Angiography Intensive Course


Friday, 27th March
15:30

19:30
Angiography Intensive Course:

Chairmen and moderation:
Albert J. Augustin (Karlsruhe, Germany)
Norbert Bornfeld (Essen, Germany)
Bernd Kirchhof (Cologne, Germany)
Case presentations by
members of the faculty


1. Introduction/ Phenomena / Differential Diagnosis
2. Retinal Vascular Diseases and AMD
3. Tumors, inflammatory and vascular occlusive diseases
4. Case presentations
19:30 Welcome dinner
Foyer Konzerthaus Karlsruhe / Foyer Concert Hall Karlsruhe
 

Symposium


Saturday, 28th March 2009
08:30

08:45
Opening Ceremony
Professor Dr. Horst Hippler
President – University of Karlsruhe, Germany
08:45

09:40
1st Scientific Session:

Microincision Surgery

Question/Topic: A real step forward or "safety first"

Chairmen and moderation:
Stanislao Rizzo (Pisa, Italy)
Gisbert Richard (Hamburg, Germany)
08:45      1 Stanislao Rizzo (Pisa, Italy)
New 25 and 23 Gauge Technologies
- How can they improve our results?
09:00      2 Periklis Brazitikos (Thessaloniki, Greece)
Instrumentation in the age of Microincision vitrectomy
The mandatory instrument set
09:15      3 Donald J. D'Amico (New York, USA)
Tipps and Tricks for Microincision Surgery
09:30      4 Stanislao Rizzo, Donald J. D'Amico
(Pisa, Italy; New York, USA)
Complications of Sutureless Vitrectomy:
Any news from the Microsurgical Safety Task Force?
09:40

10:50
2nd Scientific Session:

What is new in vitreoretinal surgery?


Chairmen and moderation:
Donald J. D'Amico (New York, USA)
Gisbert Richard (Hamburg, Germany)
09:40      5 Baruch D. Kupperman (Irvine, USA)
Macular hole surgery
Recommendations 2009 – New holes – Re-opened holes
Should we operate lamellar holes?
09:50      6 Tom S. Chang (Pasadena, USA)
Choroidal buckles: A novel method of Macular hole repair
09:55      7 Bernd Kirchhof (Cologne, Germany)
Long term results of free transplants in geographic atrophy (AMD)
10:10      8 Tom S. Chang (Pasadena, USA)
Suprachoroidal drug delivery via catheter
A Medico-Surgical Approach to wet AMD
10:20      9 Manfred R. Tetz (Berlin, Germany)
Interventional drug application
A report from outer space
10:30      10 Stanislao Rizzo, A.J. Augustin (Pisa, Italy; Karlsruhe, Germany)
PVR - A complication still frightening the surgeon?
News from medical retina?
10:40      11 Gisbert Richard (Hamburg, Germany)
Artificial Vision - A Status Report
10:50

11:10
Coffee break in the industrial exhibition area
11:10

12:50
3st Scientific Session:

Diabetic Retinopathy

New drugs/new laser technologies

Chairmen and moderation:
Neil M. Bressler (Baltimore, USA)
Antonia M. Joussen (Düsseldorf, Germany)
11:10      12 Norbert Bornfeld (Essen, Germany)
Anti-VEGF before / during / after surgery
Rationale and disease stages
11:20      13 Neil M. Bressler (Baltimore, USA)
Advanced Laser Concepts in Diabetic Retinopathy
11:35      14 Susan B. Bressler (Baltimore, USA)
Nutrition Supplementation for AMD and Diabetic Retinopathy
11:50      15 Baruch D. Kupperman (Irvine, USA)
Diabetic Retinopathy
- Medical Management in 2009 (Anti-VEGF / Steroids)
12:05      16 Susan B. Bressler (Baltimore, USA)
Laser response in diabetic macular edema (DME)
12:20      17 Neil M. Bressler (Baltimore, USA)
Vitrectomy for diabetic macular edema
Is early Vitrectomy still an approach to be considered?
12:35      18 Francesco Bandello (Udine, Italy)
DME: A comprehensive treatment algorithm
12:50

13:15
4th Scientific Session:

Tumors - An update


Chairmen and moderation:
Norbert Bornfeld (Essen, Germany)
Thorsten Böker (Dortmund, Germany)
12:50      19 Thorsten Böker (Dortmund, Germany)
Imaging of ocular tumors
Is there a #1 technique? Do we need a combination?
13:00      20 Norbert Bornfeld (Essen, Germany)
Diagnostics and Treatment of ocular melanoma in 2009
13:15

14:15
Lunch and coffee break in the industrial exhibition area

Afternoon Session: Imaging, AMD and medical Retina
14:15

15:30
5th Scientific Session:

Imaging and AMD 1


Chairmen and moderation:
Ursula Schmidt-Erfurth (Vienna, Austria)
Susan B. Bressler (Baltimore, USA)
14:15      21 Thorsten Böker (Dortmund, Germany)
Combined use of OCT / angiography / other technologies
Is this a major step forward in the diagnosis of macular diseases?
14:30      22 Ursula Schmidt-Erfurth (Vienna, Austria)
New OCT-Technologies
Spectral Domain OCT: Substance or Hype?
14:45      23 Anthony P. Adamis (New York, USA)
The role of inflammation in the pathogenesis of AMD
Prevention of Dry and Wet AMD
15:00      24 Ursula Schmidt-Erfurth (Vienna, Austria)
Wet AMD: A comprehensive treatment algorithm for all lesion types
15:15      25 William F. Mieler (Chicago, USA)
Endophthalmitis in the age of intravitreal injections
How to prevent - how to treat? Do we have to change the concept?
15:30

18:00
Coffee / Snacks in the meeting room
15:30

16:40
6th Scientific Session:

Old drugs, new drugs, combination strategies


Chairmen and moderation:
Gisele Soubrane (Cr&eacue;teil, France)
Susan B. Bressler (Baltimore, USA)
15:30      26 Periklis Brazitikos (Thessaloniki, Greece)
Pegaptanib for AMD and DME
15:40      27 Francesco Bandello (Udine, Italy)
Ranibizumab and Bevacizumab for AMD and DME
15:50      28 Antonia Joussen (Düsseldorf, Germany)
Combination strategies for wet AMD
16:00      29 Bernd Kirchhof (Cologne, Germany)
At the end of intravitreal Anti-VEGF results after termination of injection
16:10      30 William F. Mieler (Chicago, USA)
New Treatment Strategies for dry and wet AMD
What is new and promising in Phase 2 and 3
VEGF-Trap // Sirolimus // Anti-Inflammatory drugs // Fenretinide and others
16:25      31 Paolo Lanzetta (Udine, Italy)
Dexamethasone devices and other steroids for the treatment of retinal diseases. Are they changing our treatment approaches?
16:40

18:00
6th Scientific Session:

AMD 2

Dry AMD, in / off label, AMD and angiology, light toxicity

Chairmen and moderation:
Antonia M. Joussen (Düsseldorf, Germany)
Susan B. Bressler (Baltimore, USA)
16:40 Gisèle Soubrane, T.S. Chang (Créteil, France; Pasadena, USA)
Interactive Presentation
Lucentis in portions or Avastin - Is there a difference?
What is the difference between Avastin and Lucentis?
16:50 Brit Lehmann (Karlsruhe, Germany)
Prostavasin - News from the AIMS trial
17:00 Anthony P. Adamis (New York, USA)
Is there a treatment for dry AMD?
17:15 Curt Diehm (Karlsbad-Langensteinbach, Germany)
AMD and vascular diseases. Is there a common pathogenesis?
17:30 Baruch D. Kupperman (Irvine, USA)
Is topical therapy the future of AMD-treatment?
17:45 Thomas Neuhann (Munich, Germany)
Blue filtering lenses. Marketing or scientific rationale?
18:00 Discussion // Closing Remarks
Please enter your E-Mail: